KLK3 and prostate cancer: In this paper, we leverage sensing technologies to achieve ultrahigh sensitivity in detecting the prostate cancer biomarker PSA by using MNPs to capture PSA in a pre-concentration procedure for a sandwich-type immunomagnetic sensor.